Newborn Screen IDs Previously Unknown Cause of SCID

Newborn Screen IDs Previously Unknown Cause of SCID
Share on FacebookTweet about this on TwitterShare on LinkedIn

THURSDAY, Dec. 1, 2016 (HealthDay News) — Mutant BCL11B has been identified as a cause of severe combined immunodeficiency (SCID) in newborn screening, according to a study published in the Dec. 1 issue of the New England Journal of Medicine.

Divya Punwani, Ph.D., from the University of California in San Francisco, and colleagues detected SCID in a newborn before onset of infections using screening of T-cell-receptor excision circles. The affected infant was treated with allogeneic hematopoietic stem-cell transplantation on confirmation of the condition. Following exome sequencing in the patient and parents, they conducted a functional analysis of a prioritized candidate gene using hematopoietic stem cells and zebrafish embryos.

The researchers found that the infant had “leaky” SCID, with preservation of a minimal degree of immune function, craniofacial and dermal abnormalities, and absence of a corpus callosum. Hematopoietic stem-cell transplantation fully corrected his immune deficit. A heterozygous de novo missense mutation, p.N441K, in BCL11B was identified in exome sequencing. The resulting protein had dominant negative activity, which prevented the wild-type protein from binding DNA, thereby arresting T-cell lineage development and disrupting hematopoietic stem-cell migration. When recapitulated in bcl11ba-deficient zebrafish, the patient’s abnormalities were reversed by ectopic expression of functionally intact, but not mutant, human BCL11B.

“Newborn screening facilitated the identification and treatment of a previously unknown cause of human SCID,” the authors write.

Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Submit a Comment

Your email address will not be published. Required fields are marked *

9 − seven =